313 results match your criteria oncologists modified

Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors.

J Immunother Cancer 2021 07;9(7)

Harvard Medical School, Boston, Massachusetts, USA.

Expanding the US Food and Drug Administration-approved indications for immune checkpoint inhibitors in patients with cancer has resulted in therapeutic success and immune-related adverse events (irAEs). Neurologic irAEs (irAE-Ns) have an incidence of 1%-12% and a high fatality rate relative to other irAEs. Lack of standardized disease definitions and accurate phenotyping leads to syndrome misclassification and impedes development of evidence-based treatments and translational research. Read More

View Article and Full-Text PDF

How Do Breast Cancer Patients Present Following COVID-19 Early Peak in a Breast Cancer Center in Turkey?

Eur J Breast Health 2021 Jul 25;17(3):253-257. Epub 2021 Jun 25.

Breast Health Center, Acıbadem Altunizade Hospital, İstanbul, Turkey.

Objective: Coronavirus disease 2019 (COVID-19) has placed an unprecedented burden on healthcare systems and restricted resources for non-COVID patients worldwide. Treatment approaches and follow-up plans have been modified to prevent the risk of infection for patients and healthcare workers. Patients prefer to delay or cancel their treatments during the peak period of infection. Read More

View Article and Full-Text PDF

Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab.

J Immunother Cancer 2021 Jul;9(7)

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

With durable cancer responses, genetically modified cell therapies are being implemented in various cancers. However, these immune effector cell therapies can cause toxicities, including cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). Pseudogout arthritis is an inflammatory arthritis induced by deposition of calcium pyrophosphate dihydrate crystals. Read More

View Article and Full-Text PDF

Developing electronic learning to deliver MR safety training in a radiotherapy department.

J Med Imaging Radiat Sci 2021 Jul 3. Epub 2021 Jul 3.

Department of Radiotherapy, The Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom. Electronic address:

Introduction/background: Magnetic Resonance Imaging (MRI) is used in radiotherapy planning, and increasingly in on-treatment guidance. The potential for the MR environment to be hazardous, without stringent safe working practices, is real. Guidance suggests all workers in MRI undergo annual safety training. Read More

View Article and Full-Text PDF

Multidisciplinary management of elderly patients with rectal cancer: recommendations from the SICG (Italian Society of Geriatric Surgery), SIFIPAC (Italian Society of Surgical Pathophysiology), SICE (Italian Society of Endoscopic Surgery and new technologies), and the WSES (World Society of Emergency Surgery) International Consensus Project.

World J Emerg Surg 2021 Jul 2;16(1):35. Epub 2021 Jul 2.

UOC Chirurgia Generale - AOU san Giovanni di Dio e Ruggi d'Aragona, Università di Salerno, Salerno, Italy.

Background And Aims: Although rectal cancer is predominantly a disease of older patients, current guidelines do not incorporate optimal treatment recommendations for the elderly and address only partially the associated specific challenges encountered in this population. This results in a wide variation and disparity in delivering a standard of care to this subset of patients. As the burden of rectal cancer in the elderly population continues to increase, it is crucial to assess whether current recommendations on treatment strategies for the general population can be adopted for the older adults, with the same beneficial oncological and functional outcomes. Read More

View Article and Full-Text PDF

Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers.

Cancers (Basel) 2021 Jun 11;13(12). Epub 2021 Jun 11.

Medical Clinic A, Haematology, Haemostasiology, Oncology and Pulmonology, University Hospital Münster, 48149 Münster, Germany.

Oncologists face challenges in the management of SARS-CoV-2 infections and post-SARS-CoV-2 cancer treatment. We analyzed diagnostic, clinical and post-SARS-CoV-2 scenarios in patients from three German cancer centers with RT-PCR confirmed SARS-CoV-2 infection. Sixty-three patients with SARS-CoV-2 and hematologic or solid neoplasms were included. Read More

View Article and Full-Text PDF

Chondroitin Sulfate Disaccharides, a Serum Marker for Primary Serous Epithelial Ovarian Cancer.

Diagnostics (Basel) 2021 Jun 23;11(7). Epub 2021 Jun 23.

Institute of Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.

Glycosaminoglycans are long polysaccharidic chains, which are mostly present in connective tissues. Modified GAG expression in tissues surrounding malignant cells has been shown to contribute to tumor progression, aggressive status and metastasis in many types of cancer. Ovarian cancer is one of the most lethal gynecological malignancies due to its late diagnosis because of the absence of clear symptoms and unavailability of early disease markers. Read More

View Article and Full-Text PDF

Imaging diagnosis of bronchogenic carcinoma (the forgotten disease) during times of COVID-19 pandemic: Current and future perspectives.

Ravikanth Reddy

World J Clin Oncol 2021 Jun;12(6):437-457

Department of Radiology, St. John's Hospital, Bengaluru 560034, Karnataka, India.

Patients with bronchogenic carcinoma comprise a high-risk group for coronavirus disease 2019 (COVID-19), pneumonia and related complications. Symptoms of COVID-19 related pulmonary syndrome may be similar to deteriorating symptoms encountered during bronchogenic carcinoma progression. These resemblances add further complexity for imaging assessment of bronchogenic carcinoma. Read More

View Article and Full-Text PDF

Unifying the Hepatopancreatobiliary Surgery Fellowship Curriculum via Delphi Consensus.

J Am Coll Surg 2021 Jun 21. Epub 2021 Jun 21.

Departments of Surgery, University of California San Francisco, San Francisco, CA.

Background: Hepatopancreatobiliary (HPB) Fellowship training in the Americas consists of 3 distinctive routes with variable curricula: Surgical Oncology Fellowship via the Society of Surgical Oncology (SSO), Abdominal Transplant Surgery Fellowship via the American Society of Transplant Surgeons (ASTS), and HPB Fellowship via the Americas Hepato-Pancreato-Biliary Association (AHPBA). Our objective was to establish a pan-American consensus among HPB surgeons, surgical oncologists, abdominal transplant surgeons, and general surgery residency program directors (GSPDs) on a core knowledge curriculum for HPB fellowship, and to identify topics appropriate for general surgery residency and subspecialty beyond HPB fellowship.

Study Design: A 3-round modified Delphi process was used. Read More

View Article and Full-Text PDF

A Modified Delphi Study for the Development of a Leadership Curriculum for Pediatric Oncology.

Asian Pac J Cancer Prev 2021 May 1;22(5):1659-1665. Epub 2021 May 1.

Department of Public Health and Community Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.

Background: The broader construct of participatory system-wide leadership has not been highlighted in the pediatric oncology domain, although these skills are teachable. The researchers conducted the current study to develop a leadership competency curriculum for pediatric oncologists in Egypt.

Methods: The study was carried out in three phases: (1) Conducting a literature review for the years 2013-2018 to identify the initial competencies of pediatric oncology leadership (2) Holding a meeting with a superior reference panel (SRP) to get a consensus on the initial list of competencies, and (3) Conducting a two-round modified Delphi survey. Read More

View Article and Full-Text PDF

Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM).

Swiss Med Wkly 2021 05 16;151:w20501. Epub 2021 May 16.

Department of Neurology and Brain Tumour Centre, University Hospital and University of Zurich, Switzerland.

Objective: The management of brain tumour patients who would like to resume driving is complex, and needs multidisciplinary input and a consensus among treating physicians. The Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM) aim to provide guidance on how to assess “fitness-to-drive” of glioblastoma patients and to harmonise the relevant procedures in Switzerland.

Methods: At several meetings, Swiss neuro-oncologists discussed common practices on how to advise patients with a stable, i. Read More

View Article and Full-Text PDF

COVID-RO study: the radiation oncology practice at times of COVID-19 outbreak - international survey.

Rep Pract Oncol Radiother 2021 25;26(1):20-28. Epub 2021 Feb 25.

Department of Radiation Oncology, Sheba Medical Center, Tel HaShomer, Israel, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Israel.

Background: Radiation therapy (RT), an essential treatment of cancer, involves multiple hospital visits. We hypothesized that radiation departments would adjust their work patterns and RT protocols in response to the SARS-CoV-2 pandemic.

Materials And Methods: An electronic survey was sent during April 2020 to an international sample of radiation oncologists. Read More

View Article and Full-Text PDF
February 2021

Victoria (Australia) radiotherapy response to working through the first and second wave of COVID-19: Strategies and staffing.

J Med Imaging Radiat Oncol 2021 Jun 27;65(3):374-383. Epub 2021 Apr 27.

Department of Radiation Oncology, ONJ Centre, Austin Hospital, Melbourne, Victoria, Australia.

Introduction: The COVID-19 pandemic demanded a rapid response within Radiation Oncology services to minimise the risk of infection to patients and workforce. This study aimed to assess whether the operational changes put in place to reduce infection risks were effective in engaging and supporting staff.

Methods: Our service's response saw staff and patients split into morning or afternoon shifts without overlap. Read More

View Article and Full-Text PDF

Management of colorectal cancer in the era of COVID-19: Challenges and suggestions.

Sci Prog 2021 Apr-Jun;104(2):368504211010626

Department of Internal Medicine, Division of Hematology-Oncology, American University of Beirut Medical Center, Beirut, Lebanon.

The Coronavirus (COVID-19) pandemic had a huge impact on all sectors around the world. In particular, the healthcare system has been subject to an enormous pressure that has surpassed its ability in many instances. Additionally, the pandemic has called for a review of our daily medical practices, including our approach to colorectal cancer management where treatment puts patients at high risk of virus exposure. Read More

View Article and Full-Text PDF

Consensus statements on the management of metastatic renal cell carcinoma from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology 2019.

Asia Pac J Clin Oncol 2021 Apr;17 Suppl 3:27-38

Specialists Central, Central, Hong Kong.

Background: To establish a set of consensus statements for the management of metastatic renal cell carcinoma, a total of 12 urologists and clinical oncologists from two professional associations in Hong Kong formed an expert consensus panel.

Methods: Through a series of meetings and using the modified Delphi method, the panelists presented recent evidence, discussed clinical experiences, and drafted consensus statements on several areas of focus regarding the management of metastatic renal cell carcinoma. Each statement was eventually voted upon by every panelist based on the practicability of recommendation. Read More

View Article and Full-Text PDF

Burnout of health care providers during the COVID-19 pandemic: Focus on Medical Oncologists.

Int J Med Sci 2021 26;18(10):2235-2238. Epub 2021 Mar 26.

Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 00144 Rome, Italy.

The spread of the coronavirus disease 2019 (Covid-19) has challenged hard the national health system worldwide. At any level, the role of health care providers has been rapidly revisited and eventually modified to face the pandemic. The search of the balance between the provision of the most appropriate health-related services and safety of both patients and health care providers has become an indisputable necessity. Read More

View Article and Full-Text PDF

Primary Mediastinal B Cell Lymphoma in the Positron-Emission Tomography Era Executive Summary of the American Radium Society Appropriate Use Criteria.

Int J Radiat Oncol Biol Phys 2021 Mar 24. Epub 2021 Mar 24.

Department of Radiation Oncology, University of Rochester Medical Center, Rochester, New York.

Purpose: Primary mediastinal B cell lymphoma (PMBCL) is a highly curable subtype of non-Hodgkin lymphoma that is diagnosed predominantly in adolescents and young adults. Consequently, long-term treatment-related morbidity is critical to consider when devising treatment strategies that include different chemoimmunotherapy strategies with or without radiation therapy. Furthermore, adaptive approaches using the end-of-chemotherapy (EOC) positron emission tomography (PET)/computed tomography (CT) scanning may help to determine which patients may benefit from additional therapies. Read More

View Article and Full-Text PDF

Two decades of childhood cancer care in Cameroon: 2000-2020.

Pediatr Blood Cancer 2021 Jul 15;68(7):e28997. Epub 2021 Mar 15.

Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.

Background: Before the year 2000, there was no dedicated childhood cancer service in Cameroon. The aim of this study was to investigate the progress made with pediatric oncology care in Cameroon from 2000 to 2020.

Method: A literature search was conducted for published articles on childhood cancer in Cameroon and relevant documents, and conference abstracts were reviewed. Read More

View Article and Full-Text PDF

Automatic Segmentation of Clinical Target Volumes for Post-Modified Radical Mastectomy Radiotherapy Using Convolutional Neural Networks.

Front Oncol 2020 16;10:581347. Epub 2021 Feb 16.

Department of Radiation Oncology, Peking Union Medical College Hospital (CAMS), Beijing, China.

Background: This study aims to construct and validate a model based on convolutional neural networks (CNNs), which can fulfil the automatic segmentation of clinical target volumes (CTVs) of breast cancer for radiotherapy.

Methods: In this work, computed tomography (CT) scans of 110 patients who underwent modified radical mastectomies were collected. The CTV contours were confirmed by two experienced oncologists. Read More

View Article and Full-Text PDF
February 2021

Adjuvant Pancreatic Cancer Management: Towards New Perspectives in 2021.

Cancers (Basel) 2020 Dec 21;12(12). Epub 2020 Dec 21.

Service d'Oncologie Digestive et Médicale, Hôpital Paul Brousse (AP-HP), 12 Avenue Paul Vaillant Couturier, F-94800 Villejuif, France.

Adjuvant chemotherapy is currently used in all patients with resected pancreatic cancer who are able to begin treatment within 3 months after surgery. Since the recent publication of the PRODIGE 24 trial results, modified FOLFIRINOX has become the standard-of-care in the non-Asian population with localized pancreatic adenocarcinoma following surgery. Nevertheless, there is still a risk of toxicity, and feasibility may be limited in heavily pre-treated patients. Read More

View Article and Full-Text PDF
December 2020

Identifying Ovarian Cancer in Symptomatic Women: A Systematic Review of Clinical Tools.

Cancers (Basel) 2020 Dec 8;12(12). Epub 2020 Dec 8.

The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.

In the absence of effective ovarian cancer screening programs, most women are diagnosed following the onset of symptoms. Symptom-based tools, including symptom checklists and risk prediction models, have been developed to aid detection. The aim of this systematic review was to identify and compare the diagnostic performance of these tools. Read More

View Article and Full-Text PDF
December 2020

Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey.

Cardiooncology 2020 Nov 27;6(1):28. Epub 2020 Nov 27.

Franciscan Health, Indianapolis, IN, USA.

Background: Re-allocation of resources during the COVID-19 pandemic has resulted in delays in care delivery to patients with cardiovascular disease and cancer. The ability of health care providers to provide optimal care in this setting has not been formally evaluated.

Objectives: To assess the impact of COVID-19 resource re-allocation on scheduling, testing, elective procedures, telemedicine access, use of new COVID-19 therapies, and providers' opinions on healthcare policies among oncology and cardiology practitioners. Read More

View Article and Full-Text PDF
November 2020

Intensity-modulated radiation therapy (IMRT)-based concurrent chemoradiotherapy (CCRT) with Endostar in patients with pelvic locoregional recurrence of cervical cancer: Results from a hospital in the Qinghai-Tibet Plateau.

Medicine (Baltimore) 2020 Dec;99(49):e21966

Department of Radiation Oncology, Qinghai Red Cross Hospital.

The treatment of recurrent cervical cancer, especially pelvic locoregional recurrence, is very challenging for gynecologic oncologists. This study investigated the efficacy and safety of intensity-modulated radiation therapy (IMRT)-based concurrent chemoradiotherapy (CCRT) with Endostar, a novel modified recombinant human endostatin, in patients with pelvic locoregional recurrence of cervical cancer following surgical treatment.This phase 2 study was conducted between May 2018 and May 2019 at a single center in the Qinghai-Tibet Plateau and enrolled 31 patients with pelvic locoregional recurrence of cervical cancer following surgical treatment. Read More

View Article and Full-Text PDF
December 2020

Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteria.

Leuk Lymphoma 2021 05 4;62(5):1057-1065. Epub 2020 Dec 4.

University of Rochester Medical Center, Rochester, NY, USA.

This guideline for nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) by the American Radium Society was developed by a multidisciplinary expert panel of medical, pediatric, and radiation oncologists convened to formulate guidelines for evaluation and treatment. The guideline development was based on an in-depth literature review and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of the recommendations by the panel. Given the scarcity of compelling data for strong recommendations for a rare lymphoma that has been shown to be more indolent than classical Hodgkin lymphoma, in instances where evidence is not available or equivocal, expert opinion guided the recommendations. Read More

View Article and Full-Text PDF

Management of gynecological cancers in the COVID-19 era: a survey from Turkey

J Turk Ger Gynecol Assoc 2020 12;21(4):265-271

Department of Obstetrics and Gynecology, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Turkey

Objective: This study aimed to investigate how gynecologic oncologists modified their patient management during Coronavirus disease-2019 (COVID-19) in Turkey.

Material And Methods: An online survey was sent to gynecologic oncology specialists and fellows in Turkey. It included management questions about strategies for newly diagnosed or recurrent endometrial, cervical, ovarian and vulvar cancer during the pandemic. Read More

View Article and Full-Text PDF
December 2020

Development of the Oncolo-GIST ("Giving Information Strategically & Transparently") Intervention Manual for Oncologist Skills Training in Advanced Cancer Prognostic Information Communication.

J Pain Symptom Manage 2021 Jul 27;62(1):10-19.e4. Epub 2020 Nov 27.

Weill Cornell Medicine, New York, New York, USA.

Context: Patient prognostic understanding is improved by oncologists' discussions of life expectancy. Most patients deem it important to discuss prognosis with their oncologists, but a minority of cancer patients within months of death report that they had such a discussion with their oncologist.

Objectives: To query stakeholders about their perspectives on the clinical approach and utility of an Oncolo-GIST manualized communication intervention, designed to enhance oncologists' ability to convey the gist of prognostic information simply, clearly, and effectively in the setting of progressing solid tumors and limited life expectancy. Read More

View Article and Full-Text PDF

Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer.

Int J Radiat Oncol Biol Phys 2021 03 27;109(4):953-963. Epub 2020 Oct 27.

Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.

Purpose: Definitive radiation therapy (RT), with or without concurrent chemotherapy, is an alternative to radical cystectomy for patients with localized, muscle-invasive bladder cancer (MIBC) who are either not surgical candidates or prefer organ preservation. We aim to synthesize an evidence-based guideline regarding the appropriate use of RT.

Methods And Materials: We performed a Preferred Reporting Items for Systematic Reviews and Meta-analyses literature review using the PubMed and Embase databases. Read More

View Article and Full-Text PDF

Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups.

J Gynecol Oncol 2020 11;31(6):e92

Department of Gynecology, San Camillo-Forlanini Hospital, Rome, Italy.

Objective: Coronavirus disease 2019 (COVID-19) has caused rapid and drastic changes in cancer management. The Italian Society of Gynecology and Obstetrics (SIGO), and the Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies (MITO) promoted a national survey aiming to evaluate the impact of COVID-19 on clinical activity of gynecologist oncologists and to assess the implementation of containment measures against COVID-19 diffusion.

Methods: The survey consisted of a self-administered, anonymous, online questionnaire. Read More

View Article and Full-Text PDF
November 2020

Infection Prevention and Control Measures at the Children Hospital Lahore: A My Child Matters Collaborative Project.

JCO Glob Oncol 2020 10;6:1540-1545

Department of Pediatric Cardiology, The Children's Hospital and Institute of Child Health, Lahore, Pakistan.

Purpose: Infection prevention among children with cancer is a major challenge at Children Hospital Lahore (CHL), a public health care facility in Pakistan with 1,000 new pediatric cancer admissions annually. The objective has been to reduce infections through collaboration between CHL and the St Jude Children's Hospital Global Infectious Disease program via a grant by the Sanofi Espoir foundation through the My Child Matters program. The aim of the current study was to describe the effect of the collaborative improvement strategy on existing infection prevention and control (IPC) standards at CHL. Read More

View Article and Full-Text PDF
October 2020

Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe.

Radiol Oncol 2020 10 11;54(4):447-454. Epub 2020 Oct 11.

Department of Oncology, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.

Background The aim of this project was to collect real-world evidence and describe treatment patterns for stage III non-small cell lung cancer in Central and Eastern Europe. Based on real-world evidence, an expert opinion was developed, and the unmet needs and quality indicators were identified. Patients and methods A systematic literature search and a multidisciplinary expert panel of 10 physicians from 7 countries used a modified Delphi process to identify quality indicators and unmet needs in patients with stage III non-small cell lung cancer. Read More

View Article and Full-Text PDF
October 2020